| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.5 | 0.08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.09 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.09 |